DPYD*7 as a Predictor of Severe Fluoropyrimidine-Related Adverse Events.
de With M, Brufau G, van den Berg LA, de Man FM, Trajkovic M, Thijs MF, Castel R, Vermeer HJ, El Bouazzaoui S, van Hemel A, Matic M, Mathijssen RHJ, Bins S, van Schaik RHN.
de With M, et al.
JCO Precis Oncol. 2022 Jul;6:e2200180. doi: 10.1200/PO.22.00180.
JCO Precis Oncol. 2022.
PMID: 35862869